Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['miss you', 'janssen']
 we will miss you here at #asco23
VP of Oncology Global Medical Affairs at Janssen, J&J

Scientist focused on bringing new treatment options for pts with cancer. Tweets/views shared are my own